Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV001287541 | SCV001474240 | uncertain significance | Ehlers-Danlos syndrome, kyphoscoliotic type 1 | 2020-05-01 | criteria provided, single submitter | clinical testing | The PLOD1 c.128T>C; p.Leu43Pro variant in the alternate transcript NM_001316320.1, also known as c.77-3403T>C in transcript NM_000302.3, is not reported in the medical literature or gene-specific databases, to our knowledge. This variant is absent from general population databases (Exome Variant Server, Genome Aggregation Database), indicating it is not a common polymorphism. The leucine at codon 43 is weakly conserved but computational analyses (SIFT: damaging, PolyPhen-2: benign) predict conflicting effects of this variant on protein structure/function. However, this variant occurs in a weakly conserved exon that is expressed at low levels in the Genotype-Tissue Expression (GTEx) database (see link), suggesting it may not occur in physiologically relevant transcript. Nonetheless, due to limited information, the clinical significance of the p.Leu43Pro variant is uncertain at this time. References: Link to PLOD1 in GTEx Portal: https://www.gtexportal.org/home/gene/PLOD1 |